Export

Infant Bacterial Therapeutics AB

Financial information

The information source is the annual report of the company with business id 556873-8586

* Closing information (×1000) SEK

Fiscal year 202212 202112
Number of months: 12 12
Turnover: 0 0
Financial expenses: 293 Revenue Down 413 Revenue Up
Earnings before taxes: -65,451 Revenue Down -44,991 Revenue Up
Total assets: 349,619 Revenue Down 408,478 Revenue Down
Current assets: 339,031 Revenue Down 397,094 Revenue Down
Current liabilities: 17,913 Revenue Up 13,224 Revenue Up
Equity capital: 331,706 Revenue Down 395,254 Revenue Down
Share capital: 3,060 3,060
Number of employees: 7 Revenue Down 8 Revenue Down

Financial ratios

Solvency: 94.9% Revenue Down 96.8% Revenue Down
Turnover per employee: 0 0
Profitability: -Infinity% -Infinity%
Return on equity (ROE): -19.7% Revenue Down -11.4% Revenue Up
Current ratio: 1.892.7% Revenue Down 3.002.8% Revenue Down
Return on assets (ROA): -18.6% Revenue Down -10.9% Revenue Up

Companies with similar products and services, and with detailed information

Fiscal year 202212
Number of months: 12
Turnover: 0
Financial expenses: 293
Earnings before taxes: -65,451
Total assets: 349,619
Current assets: 339,031
Current liabilities: 17,913
Equity capital: 331,706
Share capital: 3,060
Number of employees: 7

Financial ratios

Solvency: 94.9%
Turnover per employee: 0
Profitability: -Infinity%
Return on equity (ROE): -19.7%
Current ratio: 1.892.7%
Return on assets (ROA): -18.6%